Seedlabs

Pinworm-Protective Lab Chow: Pumpkin-Seed Fortified Rodent Feed

A drug-free food for lab mice that prevents pinworm infections using pumpkin seed extract.

A 7-day medicated chow fortified with standardized pumpkin seed (Cucurbita maxima) extract that suppresses pinworms (Aspiculuris tetraptera) in laboratory mouse colonies — a drug-free, injection-free alternative to ivermectin that avoids confounding research endpoints.

VeterinaryHelminth infection and control
Microbial Symbiosis and ResistanceLaboratory animal science — health maintenance of research mouse colonies

Concept

Laboratory mouse colonies are chronically exposed to murine pinworms such as Aspiculuris tetraptera, and facilities today lean on injectable or water-dosed ivermectin and fenbendazole-medicated feed — both labor-intensive and both capable of interfering with study endpoints (ivermectin is neuroactive and a P-glycoprotein substrate, making it problematic for some strains and neuroscience work). This product is a pumpkin-seed-fortified rodent chow: a defined inclusion of Cucurbita maxima water or ethanol extract, fed as a 7-day course, that suppresses pinworm burden in non-SPF colonies, maintains suppression after a chemical cleanout, or bridges quarantine periods. Because the active is a food-grade seed delivered in the diet, it requires no injections, no extra animal handling, and raises no drug-residue concerns. Positioning is deliberately modest: the demonstrated effect is suppression (81–85% worm-count reduction), not eradication, so the feed is sold as a maintenance/adjunct layer paired with the same fecal monitoring used in the source study (cellophane-tape and centrifugal flotation) rather than as an SPF-qualification tool.

Why now

The new study [0] supplies the first head-to-head mammalian evidence to build on: in naturally infected Swiss albino mice, 7 days of oral pumpkin-seed extract at the human-suggested dose cut intestinal Aspiculuris burdens by 81% (water extract) and 85% (ethanol extract), versus 91% for intramuscular ivermectin at 0.2 mg/kg — a 6–10 point efficacy gap closed without a single injection, in the exact host–parasite system the product targets. The oral, feed-compatible route and human-referenced dosing make chow delivery a direct translation of the demonstrated protocol. Design constraints taken from the study: only ~29 infected mice across four groups, male animals only, and efficacy short of eradication — hence the adjunct/maintenance positioning rather than an eradication claim.

Written by GLM · 8 Oct 2026

AI assessment

Backed by 1 paper91

A pragmatic, low-risk dietary supplement for lab mouse colonies that trades absolute eradication for a non-invasive, non-confounding maintenance tool.

Evidence strength
4/5
The idea directly mirrors the study's protocol and results, including the specific parasite species and the 81-85% efficacy rate, without overclaiming eradication.
Market pull
4/5
Major lab suppliers and research institutions have a clear pain point with ivermectin's interference in neuroscience and P-gp studies.
Novelty & moat
5/5
No similar rodent-health or anthelmintic products exist in the catalog, and it addresses a specific gap in lab animal maintenance.
Feasibility
5/5
The product is a simple fortification of existing chow with a food-grade extract, requiring minimal R&D to reach MVP.
Wedge clarity
5/5
The wedge is highly specific: a 7-day maintenance course for non-SPF colonies to reduce parasite burden without injections.
Simplicity / focus
5/5
It is a single, focused product (fortified feed) rather than a complex platform or service.

Scored by Gemma 4 · 8 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • It breeds and ships thousands of genetically defined mouse strains; pinworm contamination triggers costly rederivation and shipping holds. A feed-based suppressive option requiring no injections protects colony throughput and customer confidence.

  • It runs large research-model colonies and client studies where ivermectin or fenbendazole treatment can confound endpoints and add labor. A food-grade botanical chow offers a low-interference maintenance layer between chemical treatments.

  • Envigocompany

    Envigo both operates research-model colonies and manufactures Teklad custom lab diets, making it the natural producer of a differentiated pumpkin-seed medicated feed line addressing an unmet non-drug colony health need.

  • A commercial supplier of research mice under strict health monitoring; a drug-free feed adjunct reduces reliance on medicated feed during routine colony health maintenance and quarantine.

Research it builds on

  1. Journal of Pharmacognosy and Phytotherapy
    2026 · 158 citations
    All ideas from this paper →
Leave feedback
feasibility